Contact Us
INTCO Medical Honored as a “2025 ESG Model Enterprise”
2025-06-18
On June 13, the “2025 ESG and High-Quality Development Innovation Forum” was held in Beijing, where the winners of the “Golden Antelope Outstanding Practice Cases” were announced. INTCO Medical was recognized as a “2025 ESG Model Enterprise” for its comprehensive implementation of ESG principles and commitment to sustainable development. The company received widespread recognition and acclaim across all ESG evaluation dimensions.
China’s ESG development is currently reaching a strategic crossroads, where compliance and value, domestic and international alignment, as well as passive and proactive approaches converge. All stakeholders are now required to shift from mere “formal compliance” to delivering “substantive value.”
Hosted by Time Media Group, this year’s forum brought together guests from authoritative institutions, leading enterprises, and professional associations to engage in in-depth discussions on the unique insights and approaches of ESG development in China.
The “Golden Antelope Outstanding Practice Cases” awards were established to recognize leading enterprises and individuals in the ESG field. Among them, the title of “2025 ESG Model Enterprise” honors frontrunners in ESG implementation.
As a global leader in the medical consumables industry, INTCO Medical remains committed to its mission of “Global INTCO, Global Health” The company drives industrial upgrading through technological innovation, fulfills its environmental responsibilities through green initiatives, and embraces global opportunities through open collaboration. Amid the tides of change, INTCO Medical continues to uphold innovation and responsibility, using the fruits of human intelligence to meet the evolving health needs of people worldwide.
For years, INTCO Medical has leveraged innovation as its driving force, consistently focusing on three core sectors: medical consumables, rehabilitation equipment, and physiotherapy & nursing care. The company continues to enhance its R&D capabilities and accelerate its transition to intelligent manufacturing by integrating automation and AI technologies, aiming to meet the diverse needs of customers worldwide.
In 2024, INTCO Medical invested RMB 398 million in R&D and launched 55 new products, representing a 197% increase compared to 2023.
On the path toward green transformation, INTCO Medical has positioned sustainable development as a core corporate strategy. The company has pledged to reduce carbon emissions per glove by 25% by 2030 (with 2022 as the baseline year) and to achieve carbon neutrality in its operations by 2050. In 2024, INTCO Medical continued to advance green technology innovation and application, optimizing all stages of its operations. As a result, the carbon emissions per glove dropped by 20.70% compared to the previous year. The company also generated 3.538 million kilowatt-hours of solar power and increased the number of products using FSC-certified packaging materials by 77.73% year-over-year.
As a responsible corporate citizen, INTCO Medical has established a comprehensive supply chain management system that emphasizes ESG risk control, enhances supply chain resilience, and strengthens supplier capabilities to promote coordinated development across the industry chain. In 2024 alone, INTCO Medical conducted 198 training sessions and 268 technical seminars for its suppliers, supporting improvement plans for 1,100 suppliers.
Driven by its mission to improve quality of life, INTCO Medical actively promotes inclusive healthcare by developing lightweight, intelligent mobility products and systematically implementing public welfare initiatives. By the end of 2024, the company had donated over RMB 75.82 million in charitable contributions.
INTCO Medical regards talent as its most valuable asset and is committed to creating a fair, inclusive, and human rights–respecting workplace. The company continues to improve its compensation and benefits system, supports career development, ensures occupational health and safety, and provides ample opportunities for employees to realize their personal and professional goals.
In terms of corporate governance, INTCO Medical integrates sustainable development into its management philosophy, building a modern governance structure based on the “Three Committees and One Management Team” model to protect shareholder rights. The company enforces a zero-tolerance approach to integrity and anti-corruption, reinforces risk prevention, and has established a robust information security management system to accurately identify and mitigate operational risks. Data security and privacy protection are treated with the highest importance, forming a solid foundation for sustainable corporate growth.
For INTCO Medical, ESG practices are proactive initiatives under the broader concept of sustainable development. The “2025 ESG Model Enterprise” award serves as strong recognition of the company’s comprehensive ESG efforts and achievements. ESG is a shared ecosystem that requires joint efforts from all participants. As an active contributor, INTCO Medical will continue to deepen its ESG strategy and collaborate with partners across sectors to jointly build a sustainable future.
